Determination of lamivudine and zidovudine permeability using a different ex vivo method in Franz cells

Journal of Pharmacological and Toxicological Methods

Volumn 67, Issue 3, 2013, Pages 194-202

  Dezani, André Bersani ^a   Pereira, Thaisa Marinho ^a   Caffaro, Arthur Massabki ^a   Reis, Juliana Mazza ^a   Serra, Cristina Helena dos Reis ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biopharmaceutical Classification System; Franz cells; Lamivudine; Methods; Permeability; Zidovudine

Indexed keywords

FLUORESCEIN; LAMIVUDINE; METOPROLOL; ZIDOVUDINE;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; DRUG PENETRATION; EX VIVO STUDY; FRANZ CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE MUCOSA PERMEABILITY; JEJUNUM; MALE; MEMBRANE; NONHUMAN; RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; CELL MEMBRANE PERMEABILITY; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; JEJUNUM; LAMIVUDINE; MALE; RATS; RATS, WISTAR; SOLUBILITY; ZIDOVUDINE;

EID: 84875623256     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2013.01.005     Document Type: Article

References (81)

1. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research 1995, 12:413-420.
2. Artursson P., Ungell A.-L., Löfroth J.-E. Selective paracellular permeability in two models of intestinal absorption: Cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharmaceutical Research 1993, 10:1123-1129.
3. Aungst B.J. P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs. Advanced Drug Delivery Reviews 1999, 39:105-116.
4. Aymard G., Legrand M., Trichereau N., Diquet B. Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography. Journal of Chromatography. B, Biomedical Sciences and Applications 2000, 744:227-240.
5. Balimane P.V., Chong S., Morrison R.A. Current methodologies used for evaluation of intestinal permeability and absorption. Journal of Pharmacological and Toxicological Methods 2000, 44:301-312.
6. Balimane P.V., Han Y.-H., Chong S. Current industrial practices of assessing permeability and P-glycoprotein interaction. The AAPS Journal 2006, 8:E1-E13.
7. Balint G.A. Antiretroviral therapeutic possibilities for human immunodeficiency virus/acquired immunodeficiency syndrome. Pharmacology & Therapeutics 2001, 89:17-27.
8. Berginc K., Zakelj S., Levistk L., Ursic D., Kristl A. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum. European Journal of Pharmaceutics and Biopharmaceutics 2007, 66:281-285.
9. Breda S.A., Jimenez-Kairuz A.F., Manzo R.H., Olivera M.E. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxaxin and norfloxacin pharmaceutical derivatives. International Journal of Pharmaceutics 2009, 371:106-113.
10. Cao X., Gibbs S.T., Fang L., Miller H.A., Landowski C.P., Shin H.-C., et al. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharmaceutical Research 2006, 23:1675-1686.
11. Cao X., Yu L.X., Sun D. Drug absorption principles. Biopharmaceutics applications in drug development 2008, 75-100. Springer, New York. R. Krishna, L. Yu (Eds.).
12. Checa A., Soto V.G., Hernández-Cassou S., Saurina J. Fast determination of pKa values of reverse transcriptase inhibitor drugs for AIDS treatment by using pH-gradient flow-injection analysis and multivariate curve resolution. Analytica Chimica Acta 2005, 554:177-183.
13. Cook T.J., Shenoy S.S. Intestinal permeability of chlorpyrifos using the single pass intestinal perfusion method in the rat. Toxicology 2003, 184:125-133.
14. Corá L.A., Américo M.F., Oliveira L.B., Serra C.H.R., Baffa O., Evangelista R.C., et al. Biomagnetic methods: Technologies applied to pharmaceutical research. Pharmaceutical Research 2011, 28:438-455.
15. Dahan A., Amidon G.L. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: The role of efflux transport in the oral absorption of BCS class III drugs. Molecular Pharmaceutics 2009, 6:19-28.
16. Dahan A., Hoffman A. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: The ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. European Journal of Pharmaceutics and Biopharmaceutics 2007, 67:96-105.
17. Dahan A., West B.T., Amidon G.L. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat. European Journal of Pharmaceutical Sciences 2009, 36:320-329.
18. Deferme S., Annaert P., Augustijns P. In vitro screening models to assess intestinal drug absorption and metabolism. Drug absorption studies: In situ, in vitro and in silico models 2008, 182-215. Springer, New York. C. Ehrhardt, K.-J. Kim (Eds.).
19. El-Kattan A., Varma M. Oral absorption, intestinal metabolism and human oral bioavailability. Topics on drug metabolism 2012, 1-34. InTech. J. Paxton (Ed.).
20. Fagerholm U., Johansson M., Lennernäs H. Comparison between permeability coefficients in rat and human jejunum. Pharmaceutical Research 1996, 13:1336-1342.
21. Fagerholm U., Lennernäs H. Experimental estimation of the effective unstirred water layer thickness in the human jejunum, and its importance in oral drug absorption. European Journal of Pharmaceutical Sciences 1995, 3:247-253.
22. Flaten G.E., Dhanikula A.B., Luthman K., Brandl M. Drug permeability across a phospholipid vesicle based barrier: A novel approach for studying passive diffusion. European Journal of Pharmaceutical Sciences 2006, 27:80-90.
23. Food and Drug Administration Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system, Rockville (accessed July 2011). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070246.pdf.
24. Grabovac V., Bernkop-Schnürch A. Improvement of the intestinal membrane permeability of low molecular weight heparin by complexation with stem bromelain. International Journal of Pharmaceutics 2006, 326:153-159.
25. Grass G.M. Simulation models to predict oral drug absorption from in vitro data. Advanced Drug Delivery Reviews 1997, 23:199-219.
26. Hamid K.A., Katsumi H., Sakane T., Yamamoto A. The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats. International Journal of Pharmaceutics 2009, 379:100-108.
27. Herai H., Gratieri T., Thomazine J.A., Bentley M.V.L.B., Lopez R.F.V. Doxorubicin skin penetration from monoolein-containing propylene glycol formulations. International Journal of Pharmaceutics 2007, 329:88-93.
28. Hidalgo I.J., Ryan F.M., Marks G.J., Smith P.L. pH-dependent transepithelial transport of cephalexin in rabbit intestinal mucosa. International Journal of Pharmaceutics 1993, 98:83-92.
29. Hillgren K.M., Kato A., Borchardt R.T. In vitro systems for studying intestinal drug absorption. Medicinal Research Reviews 1995, 15:83-109.
30. Itagaki S., Otsuka Y., Kubo S., Okumura H., Saito Y., Kobayashi M., et al. Intestinal uptake of nateglinide by an intestinal fluorescein transporter. Biochimica et Biophysica Acta 2005, 1668:190-194.
31. Jain R., Duvvuri S., Kansara V., Mandava N.K., Mitra A.K. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats. International Journal of Pharmaceutics 2007, 336:233-240.
32. Kerns E.H., Di L., Petuskiy S., Farris M., Ley R., Jupp P. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. Journal of Pharmaceutical Sciences 2004, 93:1440-1453.
33. Kim J.-S., Mitchell S., Kijek P., Tsume Y., Hilfinger J., Amidon G.L. The suitability of an in situ perfusion model for permeability determinations: Utility for BCS class I biowaiver requests. Molecular Pharmaceutics 2006, 3:686-694.
34. Koljonen M., Hakala K.S., Ahtola-Sätilä T., Laitinen L., Kostiainen R., Kotiaho T., et al. Evaluation of cocktail approach to standardise Caco-2 permeability experiments. European Journal of Pharmaceutics and Biopharmaceutics 2006, 64:379-387.
35. Konishi Y., Hagiwara K., Shimizu M. Transepithelial transport of fluorescein in Caco-2 cell monolayers and use of such transport in in vitro evaluation of phenolic acid availability. Bioscience, Biotechnology, and Biochemistry 2002, 66:2449-2457.
36. Kuwayama K., Miyauchi S., Tateoka R., Abe H., Kamo N. Fluorescein uptake by amonocarboxylic acid transporter in human intestinal Caco-2 cells. Biochemical Pharmacology 2002, 63:81-88.
37. Lane M.E., Levis K.A., Corrigan O.I. Effect of intestinal fluid flux on ibuprofen absorption in the rat intestine. International Journal of Pharmaceutics 2006, 309:60-66.
38. Langguth P., Kubis A., Krumbiegel G., Lang W., Merkle H.P., Wächter W., et al. Intestinal absorption of the quaternary trospium chloride: Permeability-lowering factors and bioavailabilities for oral dosage forms. European Journal of Pharmaceutics and Biopharmaceutics 1997, 43:265-272.
39. Legen I., Kristl A. pH and energy dependent transport of ketoprofen across rat jejunum in vitro. European Journal of Pharmaceutics and Biopharmaceutics 2003, 56:87-94.
40. Legen I., Salobir M., Kerc J. Comparison of different intestinal epithelia as models for absorption enhancement studies. International Journal of Pharmaceutics 2005, 291:183-188.
41. Lennernäs H. Human intestinal permeability. Journal of Pharmaceutical Sciences 1998, 87:403-410.
42. Lennernäs H. Animal data: The contributions of the Ussing chamber and perfusion systems to predicting human oral drug delivery in vivo. Advanced Drug Delivery Reviews 2007, 59:1103-1120.
43. Lennernäs H., Abrahamsson B. The use of biopharmaceutic classification of drugs in drug discovery and development: Current status and future extension. The Journal of Pharmacy and Pharmacology 2005, 57:273-285.
44. Lennernäs H., Nylander S., Ungell A.-L. Jejunal permeability: A comparison between the Ussing chamber technique and the single-pass perfusion in humans. Pharmaceutical Research 1997, 14:667-671.
45. Li F., Hong L., Mau C.-I., Chan R., Hendricks T., Dvorak C., et al. Transport of levovirin prodrugs in the human intestinal Caco-2 cell line. Journal of Pharmaceutical Sciences 2006, 95:1318-1325.
46. Li C., Nair L., Liu T., Li F., Pichardo J., Agrawal S., et al. Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors. Biochemical Pharmacology 2008, 75:1186-1197.
47. Lopez R.F.V., Collett J.H., Bentley M.V.L.B. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. International Journal of Pharmaceutics 2000, 200:127-132.
48. Masaoka Y., Tanaka Y., Kataoka M., Sakuma S., Yamashita S. Site of drug absorption after oral administration: Assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract. European Journal of Pharmaceutical Sciences 2006, 29:240-250.
49. Masungi C., Mensch J., Van Dijck A., Borremans C., Willems B., Mackie C., et al. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates. Die Pharmazie 2008, 63:194-199.
50. Menon R.M., Barr W.H. Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chambers. Biopharmaceutics & Drug Disposition 2003, 24:299-308.
51. Mineo H., Hara H., Shigematsu N., Okuhara Y., Tomita F. Melibiose, difructose anhydride III and difructose anhydride IV enhance net calcium absorption in rat small and large intestinal epithelium by increasing the passage of tight junctions in vitro. The Journal of Nutrition 2002, 132:3394-3399.
52. Motz S.A., Schaefer U.F., Balbach S., Eichinger T., Lehr C.-M. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell. European Journal of Pharmaceutics and Biopharmaceutics 2007, 66:286-295.
53. Muendoerfer M., Schaefer U.F., Koenig P., Walk J.S., Loos P., Balbach S., et al. On line monitoring of transepithelial electrical resistance (TEER) in an apparatus for combined dissolution and permeation testing. International Journal of Pharmaceutics 2010, 392:134-140.
54. Neuhoff S., Ungell A.-L., Zamora I., Artursson P. pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: Implications for drug-drug interactions. Pharmaceutical Research 2003, 20:1141-1148.
55. Nicolazzo J.A., Finnin B.C. In vivo and in vitro models for assessing drug absorption across the bucal mucosa. Drug absorption studies: In situ, in vivo and in silico models 2008, 89-111. Springer, New York. C. Ehrhardt, K.-J. Kim (Eds.).
56. Ong C.M.Y., Heard C.M. Permeation of quinine across sublingual mucosa in vitro. International Journal of Pharmaceutics 2009, 366:58-64.
57. Pretorius E., Bouic P.J.D. Permeation of four oral drugs through human intestinal mucosa. AAPS PharmSciTech 2009, 10:270-275.
58. Quevedo M.A., Briñon M.C. In vitro and in vivo pharmacokinetics characterization of two novel prodrugs of zidovudine. Antiviral Research 2009, 83:103-111.
59. Reis J.M., Sinko B., Serra C.H.R. Parallel artificial membrane permeability assay (PAMPA) - Is it better than Caco-2 for human passive permeability prediction?. Mini Reviews in Medicinal Chemistry 2010, 10:1071-1076.
60. Röpke C.D., Kaneko T.M., Rodrigues R.M., Silva V.V., Barros S., Sawada T.C.H., et al. Evaluation of percutaneous absorption of 4-nerolidylcathecol from four topical formulation. International Journal of Pharmaceutics 2002, 249:109-116.
61. Ruan L.P., Chen S., Yu B.Y., Zhu D.N., Cordell G.A., Qiu S.X. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. European Journal of Medicinal Chemistry 2006, 41:605-610.
62. Sandri G., Bonferoni M.C., Rossi S., Ferrari F., Gibin S., Zambito Y., et al. Nanoparticles based on N-trimethylchitosan: Evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models. European Journal of Pharmaceutics and Biopharmaceutics 2007, 65:68-77.
63. Sharma P., Chawla H.P.S., Panchagnula R. LC determination of cephalosporins in in vitro rat intestinal sac absorption model. Journal of Pharmaceutical and Biomedical Analysis 2002, 27:39-50.
64. Skolnik S., Lin X., Wang J., Chen X.-H., He T., Zhang B. Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay. Journal of Pharmaceutical Sciences 2010, 99:3246-3265.
65. Souza J., Benet L.Z., Huang Y., Storpirtis S. Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and Caco-2 cell monolayers. Journal of Pharmaceutical Sciences 2009, 98:4413-4419.
66. Souza J., Freitas Z.M.F., Storpiritis S. Modelos in vitro para determinação da absorção de fármacos e previsão da relação dissolução/absorção. Brazilian Journal of Pharmaceutical Sciences 2007, 43:515-527.
67. Steffansen B., Nielsen C.U., Brodin B., Eriksson A.H., Andersen R., Frokjaer S. Intestinal solute carriers: An overview of trends and strategies for improving oral drug absorption. European Journal of Pharmaceutical Sciences 2004, 21:3-16.
68. Sugano K., Hamada H., Machida M., Ushio H., Saitoh K., Terada K. Optimized conditions of bio-mimetic artificial membrane permeation assay. International Journal of Pharmaceutics 2001, 228:181-188.
69. Sutton S.C., Rinaldi M.T.S., Vukovinsky K.E. Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. The AAPS Journal 2001, 3:1-5.
70. Thomas K.E., Sapone A., Fasano A., Vogel S.N. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are myD88-dependent: Role of the innate immune response in celiac disease. Journal of Immunology 2006, 176:2512-2521.
71. Thomson A.B.R., Dietchy J.M. The role of the unstirred water layer in intestinal permeation. Pharmacology of intestinal permeation II 1984, Springer, Berlin. T.Z. Csaky (Ed.).
72. Trapani G., Franco M., Trapani A., Lopedota A., Latrofa A., Gallucci E., et al. Frog intestinal sac: A new in vitro method for the assessment of intestinal permeability. Journal of Pharmaceutical Sciences 2004, 93:2909-2919.
73. Tukker J.J. In vitro methods for the assessment of permeability. Oral drug absorption: Prediction and assessment 2000, 51-72. Marcel Dekker, New York. J.B. Dressman, H. Lennernäs (Eds.).
74. Uchida M., Fukazawa T., Yamazaki Y., Hashimoto H., Miyamoto Y. A modified fast (4days) 96-well plate Caco-2 permeability assay. Journal of Pharmacological and Toxicological Methods 2009, 59:39-43.
75. Watanabe E., Takahashi M., Hayashi M. A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method. European Journal of Pharmaceutics and Biopharmaceutics 2004, 58:659-665.
76. Yao H.-M., Chiou W.L. The complexity of intestinal absorption and exorption of digoxin in rats. International Journal of Pharmaceutics 2006, 322:79-86.
77. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - Fact or myth. Pharmaceutical Research 1997, 14:763-766.
78. Yu H., Sinko P.J. Influence of the microporous substratum and hydrodynamics on resistances to drug transport in cell culture systems: Calculation of intrinsic transport parameters. Journal of Pharmaceutical Sciences 1997, 86:1448-1457.
79. Zakelj S., Sturm K., Kristl A. Ciprofloxacin permeability and its active secretion through rat small intestine in vitro. International Journal of Pharmaceutics 2006, 313:175-180.
80. Zambito Y., Zaino C., Uccello-Barretta G., Balzano F., Di Colo G. Improved synthesis of quaternary ammonium-chitosan conjugates (N+-Ch) for enhanced intestinal drug permeation. European Journal of Pharmaceutical Sciences 2008, 33:343-350.
81. Zhu C., Jiang L., Chen T.-M., Hwang K.-K. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. European Journal of Medicinal Chemistry 2002, 37:399-407.